GGrantIndex
← Leaderboards

Ramakrishna Vankayalapati

University Of Texas Hlth Ctr At Tyler

$8,387,695
Attributed
$8,387,695
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$8,387,695 · 9

By mechanism

R01$6,505,521 · 4
R21$1,529,674 · 4
R56$352,500 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Hlth Ctr At Tyler

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingProductionPersonsTuberculosisMycobacterium TuberculosisImmunityCellsCytokineResponseInfectionMonocyteMacrophagePreventCessation Of LifeBaseIl2ra GeneGrowthT-LymphocyteImmune ResponseCause Of DeathNatural Killer CellsPublishingVaccinesSite

Grant awards (26)

Innate immune response of LTBI+HIV+ children$726,289
R01 · FY2024 · AI · contact PI
Innate immune response of LTBI+HIV+ children$1
R01 · FY2024 · AI · contact PI
Innate immune response of LTBI+HIV+ children$695,140
R01 · FY2022 · AI · contact PI
Innate immune response of LTBI+HIV+ children$695,140
R01 · FY2021 · AI · contact PI
Innate immune response of LTBI+HIV+ children$718,640
R01 · FY2020 · AI · contact PI
IFN-γ independent inhibition of MTB growth in human macrophages$495,150
R01 · FY2020 · AI · contact PI
IFN-γ independent inhibition of MTB growth in human macrophages$349,550
R01 · FY2019 · AI · contact PI
IFN-γ independent inhibition of MTB growth in human macrophages$349,550
R01 · FY2018 · AI · contact PI
IFN-γ independent inhibition of MTB growth in human macrophages$360,800
R01 · FY2017 · AI · contact PI
Monocyte subpopulation in HIV+LTB+ individuals and development of active TB$172,514
R21 · FY2017 · AI · contact PI
Monocyte subpopulation in HIV+LTB+ individuals and development of active TB$220,014
R21 · FY2016 · AI · contact PI
T-regs mediated immune responses in LTBI HIV positive individuals$169,676
R21 · FY2016 · AI · contact PI
T-regs mediated immune responses in LTBI HIV positive individuals$216,176
R21 · FY2015 · AI · contact PI
Treg suppression of islet allograft rejection$279,180
R01 · FY2014 · AI · contact PI
Treg suppression of islet allograft rejection$262,429
R01 · FY2013 · AI · contact PI
Treg suppression of islet allograft rejection$279,180
R01 · FY2012 · AI · contact PI
The role of NK cells in HIV and tuberculosis co-infection$188,669
R21 · FY2012 · AI · contact PI
The role of NK cells in HIV and tuberculosis co-infection$193,875
R21 · FY2011 · AI · contact PI
The mechanisms of regulatory T-cell expansion in human Mycobacterium tuberculosis$352,500
R56 · FY2010 · AI · contact PI
The role of NK cells in human M. Tuberculosis infection$255,795
R01 · FY2009 · AI · contact PI
The role of regulatory T cells in M. tuberculosis infection$171,875
R21 · FY2009 · AI · contact PI
The role of NK cells in human M. Tuberculosis infection$255,795
R01 · FY2008 · AI · contact PI
The role of regulatory T cells in M. tuberculosis infection$196,875
R21 · FY2008 · AI · contact PI
The role of NK cells in human M. Tuberculosis infection$260,750
R01 · FY2007 · AI · contact PI
The role of NK cells in human M. Tuberculosis infection$268,538
R01 · FY2006 · AI · contact PI
The role of NK cells in human M. Tuberculosis infection$253,594
R01 · FY2005 · AI